> The internal audit for this case analysis is presented in the form of a SWOT (strengths-weaknesses-opportunities-threats) analysis for Nigerian Hoechst Limited, a subsidiary of Hoechst A.G. The SWOT analysis includes considerations of each of the major functional departments of Nigerian Hoechst Limited - production, marketing, finance, and regulatory affairs. The SWOT analysis is presented in chart form. The chart may be found on the following page.
SWOT Analysis: Nigerian Hoechst Limited
1. Hoechst pharmaceutical products are well accepted by consumers
2. Nigerian Hoechst is well established in the ethical segment of the pharmaceutical market in Nigeria
3. Hoechst has existing proprietary pharmaceutical products that are suitable for introduction in the OTC market in Nigeria
1. Nigerian Hoechst does not have established distribution channels for the OTC pharmaceutical market in Nigeria
2. Hoechst's existing proprietary pharmaceutical products have not been approved for OTC distribution in Nigeria
3. Neither Hoechst nor Nigerian Hoechst has a culture that accepts and focuses on proprietary pharmaceuticals
1. The OTC pharmaceutical market in Nigeria is much larger than the ethical drug market; providing Nigerian Hoechst with an opportunity to expand sal
...